LANCET RHEUMATOL 潤(rùn)色咨詢(xún)

Lancet Rheumatology

出版年份:2019 年文章數(shù):153 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:12 issues/year 自引率:暫無(wú)數(shù)據(jù) 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢(xún)

投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量1.72% (2022年為1.38%)
自引率
暫無(wú)數(shù)據(jù)
年文章數(shù)
153
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):4849)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):1820次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):3593次)
NCBI查詢(xún)
期刊簡(jiǎn)介
稿件收錄要求

The Lancet Rheumatology is an independent, monthly journal committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy.

We invite submissions of clinical research (with a focus on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis and classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. The journal also publishes high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance efforts toward precision medicine, or have the potential to directly inform future clinical trials. With a strong clinical focus, The Lancet Rheumatology provides an independent voice for the rheumatology community and advocates strongly for the improved lives of patients with rheumatic diseases around the globe.